Glenmark Pharmaceuticals Ltd
₹2331
(0.16%)
Thu, 08 Oct 2026, 07:26 pm
Glenmark Pharmaceuticals News
Glenmark launches Adapalene Gel pump packs in US
Glenmark Therapeutics Inc. USA introduced Adapalene Gel USP, 0.1% in new pump packs, targeting a $45.8 million annual market for the Differin equivalent.
06 Oct 2026
companies
Glenmark closes trading window for Q2FY27 results
Glenmark Pharmaceuticals has closed its trading window from October 1, 2026, until 48 hours after the declaration of Q2FY27 financial results.
28 Sept 2026
companies
Glenmark Pharma shares flag large-trade signal on NSE
A large-trade signal flagged approximately 1,50,735 Glenmark Pharmaceuticals shares changing hands on NSE at ₹2,473.00, with combined value of ₹37.28 crore.
23 Sept 2026
equity-markets
Glenmark Pharma gets EIR from U.S. FDA for Goa facility
Glenmark Pharmaceuticals has received an Establishment Inspection Report from the U.S. FDA for its Goa facility, with a Voluntary Action Indicated status.
23 Sept 2026
companies
Glenmark Pharma to host analyst meet in Mumbai
Glenmark Pharmaceuticals Ltd will hold an analyst and institutional investor meeting on September 29, 2026, in Mumbai for the PL Capital Emerging Titans 2026 Conference.
21 Sept 2026
companies
Market Current News
CENTURY EXTRUSIONS LTD.
Century Extrusions extends rights issue deadline
Century Extrusions Ltd has extended the closing date of its ongoing rights issue to October 21, 2026. Allotment is scheduled for October 22, 2026.
07 Oct 2026
ipo
Salem Erode Investments Ltd.
Salem Erode Investments rights issue oversubscribed
Salem Erode Investments Limited reported 102.47% subscription for its ₹2,293.10 lakh rights issue, with allotment finalized on October 5, 2026.
07 Oct 2026
ipo
RK Fashion IPO Day 2: Subscribed 0.94x
RK Fashion Accessories IPO sees QIB demand at 14.11x but overall subscription at 0.94x on Day 2. Retail demand remains weak at 0.73x.
07 Oct 2026
ipo
HD Fire Protect IPO: ₹489 Cr Revenue; OFS Only
HD Fire Protect, India's 2nd largest fire protection manufacturer, files DRHP for an Offer for Sale. Revenue hit ₹489.28 crore in FY26 with 14.54% CAGR.
07 Oct 2026
ipo
RBI revises USD/INR assumption to 95 for FY27
The Reserve Bank of India has revised its USD/INR exchange rate assumption to 95 for FY27, up from the earlier assumption of 94.
07 Oct 2026
currency